Close

Senate Republicans “Have Just Gone On The Record In Favor Of Expensive Insulin”

MSNBC: “Among the 43 were quite a few senators who are up for re-election this year, including Wisconsin’s Ron Johnson, Florida’s Marco Rubio”
Fortune: “Democrats immediately attacked Senators Ron Johnson of Wisconsin and Marco Rubio of Florida, who are up for re-election, over their votes to strip a $35 insulin cap from the tax bill”

A wave of news coverage is calling out Senate Republicans who voted to block the “cap on insulin costs for millions of patients” – including “quite a few senators who are up for re-election this year” like Ron Johnson and Marco Rubio who were “immediately attacked” for siding with Big Pharma.

See for yourself:

  • MSNBC: Senate Republicans derail insulin price cap for many consumers. “Among the 43 were quite a few senators who are up for re-election this year, including Wisconsin’s Ron Johnson, Florida’s Marco Rubio, Iowa’s Chuck Grassley, and Utah’s Mike Lee — each of whom could’ve done the popular thing to help consumers, but they chose not to.”
  • Rolling Stone: Insulin Will Remain Expensive for Many, Thanks to Republicans. “‘Republicans have just gone on the record in favor of expensive insulin,’ Sen. Ron Wyden (D-Ore.) said after Republicans voted to remove an insulin price cap from the Inflation Reduction Act. ‘After years of tough talk about taking on insulin makers, Republicans have once agains wilted in the face of heat from Big Pharma.’”

###

Next Post

ICYMI: ‘Doc Hollywood’: In A Twist, Democrats Attack A Senate Candidate, Mehmet Oz, For His Showbiz Ties [Deadline]

Stay Connected


DSCC FRIDAY TAKEAWAYS: SENATE REPUBLICANS HAVE A CANDIDATE QUALITY PROBLEM, DSCC DETAILS ADVERTISING & SENATE DEMS DOMINATE...

3 days Ago

ago on Twitter

Close

Defend Our Democratic
Senate Majority


Sign up to receive text updates. By participating, you consent to receive recurring committee & fundraising messages from the DSCC, including automated text messages. Msg & Data rates may apply. Privacy Policy & ToS.

or